SER P/E Ratio
P/E Ratio as of Jun 13, 2025: -1.01
Average-0.9845
Median-0.9900
Minimum-1.04
Maximum-0.9100
-1.01
Past Month-0.06 (6.32%)
The P/E ratio for SER is -1.01 as of Jun 13, 2025. This represents a increase of 26.25% compared to its 12-month average P/E ratio of -0.8. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.
Serina Therapeutics, Inc. P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Serina Therapeutics, Inc.’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Serina Therapeutics, Inc. to industry peers.
Serina Therapeutics, Inc. P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Serina Therapeutics, Inc.’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Serina Therapeutics, Inc. to industry peers.
SER P/E Ratio Insights
See Serina Therapeutics, Inc.’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in SER
Order type
Buy in
Order amount
Est. shares
0 shares
SER P/E Ratio Historic Data
| Date | Stock price | P/E ratio |
|---|---|---|
| Jun 2, 2025 | $5.90 | -0.99 |
| May 1, 2025 | $5.31 | -0.89 |
| Apr 1, 2025 | $5.34 | -0.90 |
| Mar 3, 2025 | $4.9673 | -0.84 |
| Feb 3, 2025 | $4.91 | -0.83 |
| Jan 2, 2025 | $5.10 | -0.86 |
SER End of Year P/E Ratio
| Date | P/E ratio | Change |
|---|---|---|
| 2025 | -1.01 | +20.24% |
| 2024 | -0.84 | -19.23% |
| 2023 | -1.04 | -50.71% |
| 2022 | -2.11 | -55.67% |
| 2021 | -4.76 | -9.68% |
| 2020 | -5.27 | — |
FAQs About Serina Therapeutics, Inc. (SER) P/E ratio
The latest P/E ratio of SER is -1.01, as of Jun 13, 2025. This is calculated based on its current stock price and earnings per share (EPS).
Serina Therapeutics, Inc.’s last 12-month average P/E ratio is -0.8, compared to its current P/E ratio of -1.01. This reflects a increase of 26.25%.
Serina Therapeutics, Inc.’s current P/E ratio of -1.01 is higher than its last 12-month average P/E of -0.8. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.
Serina Therapeutics, Inc.’s average P/E ratio over the last 3 years is -1.5. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.
Serina Therapeutics, Inc.’s average P/E ratio over the last 5 years is -2.66. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.